E. Gasnier

DUCHENNE MUSCULAR DYSTROPHY - PHYSIOTHERAPY P.312Factors influencing spontaneous maximal stride speed in individual Duchenne muscular dystrophy boys

D. Vissière, L. Servais, T. Gidaro, 2018, Neuromuscular Disorders.

Large CTG repeats trigger p16-dependent premature senescence in myotonic dystrophy type 1 muscle precursor cells.

A. Bigot, G. Butler-Browne, V. Mouly, 2009, The American journal of pathology.

A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment

Thomas Voit, David Vissière, Jean-Yves Hogrel, 2016, PloS one.

Home‐based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy

D. Vissière, L. Servais, J. Vissing, 2022 .

New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats

A. Sureau, J. Marie, D. Furling, 2011, Nucleic acids research.

Gain of RNA function in pathological cases: Focus on myotonic dystrophy.

D. Furling, A. Klein, E. Gasnier, 2011, Biochimie.

Home-Based Monitor for Gait and Activity Analysis.

Marc Grelet, David Vissière, Laurent Servais, 2019, Journal of visualized experiments : JoVE.

P.429 Innovative home activity monitoring in non-ambulant patients with spinal muscular atrophy: a multicenter observational trial

D. Vissière, L. Servais, Y. Péréon, 2017, Neuromuscular Disorders.